Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomas.

Abstract	Survivin is a member of the inhibitor of apoptosis protein family. Gliomas and many other tumors express survivin at high levels; whereas, normal fully differentiated cells generally do not. Therefore, survivin represents a tumor-specific target for cancer vaccine therapy. It has been shown that it is possible to produce a MHC-I-restricted cellular immunologic response to survivin vaccines. To study differences in immunogenicity between murine and human survivin proteins, we vaccinated C57BL/6 mice with bone marrow dendritic cells (BMDC) transfected with expression vectors containing the murine and human survivin genes. Mice vaccinated with BMDCs expressing a truncated human survivin protein developed cytotoxic T lymphocyte to subcutaneous GL261 glioma cells and exhibited prolonged tumor-free survival compared to mice vaccinated with BMDCs transfected with vector alone (P<0.01). While mice challenged with intracerebral GL261 cells had increased survival, no cures were observed. In contrast, vaccinated mice that fully resisted subcutaneous tumor challenge were rendered resistant to intracerebral GL261 re-challenge. BMDCs transfected with the full-length human survivin molecule were significantly more effective at prolonging survival than BMDCs expressing the full-length murine survivin gene (P=0.0175). Therefore, xenogeneic differences between human and murine sequences might be exploited to develop more immunogenic tumor vaccines.
Authors	Michael J Ciesielski, Lisa Apfel, Tara A Barone, Carla A Castro, Tina C Weiss, Robert A Fenstermaker
Journal	Cancer immunology, immunotherapy : CII (Cancer Immunol Immunother) Vol. 55 Issue 12 Pg. 1491-503 (Dec 2006) ISSN: 0340-7004 [Print] Germany
PMID	16485128 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References	Antigens, Heterophile BIRC5 protein, human Birc5 protein, mouse Cancer Vaccines Inhibitor of Apoptosis Proteins Microtubule-Associated Proteins Neoplasm Proteins Repressor Proteins Survivin
Topics	Animals Antigens, Heterophile (genetics) Apoptosis Autoimmunity Bone Marrow Cells (immunology, metabolism) Bone Marrow Transplantation Brain Neoplasms (drug therapy) Cancer Vaccines (chemical synthesis, immunology, therapeutic use) Cytotoxicity, Immunologic Dendritic Cells (immunology, metabolism, transplantation) Glioma (drug therapy) Humans Immunotherapy, Adoptive Inhibitor of Apoptosis Proteins Mice Mice, Inbred C57BL Microtubule-Associated Proteins (genetics, immunology) Neoplasm Proteins (genetics, immunology) Repressor Proteins Survivin Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!